MDS: what treatments are on the horizon?
Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, outlines therapies on the horizon for both high and low-risk myelodysplastic syndromes. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
Get great new content delivered to your inboxSign up
More from Rafael Bejar